Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir.
Chung-Feng HuangMing-Lun YehChing-I HuangPo-Cheng LiangYi-Hung LinMing-Yen HsiehKuan-Yu ChenYu-Min KoZu-Yau LinShinn-Cherng ChenJee-Fu HuangChia-Yen DaiWan-Long ChuangMing-Lung YuPublished in: Journal of gastroenterology and hepatology (2019)
Adding RBV to DAAs improved early viral kinetic, in particular, for intermediate responders.
Keyphrases